AMNEAL PHARMACEUTICALS, INC. Earnings Per Share, Basic and Diluted
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Earnings Per Share, Basic and Diluted of -$2.74 per share for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-02.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2020-03-02
- AMNEAL PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2019-06-30 was -$0.13.
- AMNEAL PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2019-03-31 was -$0.37.
- AMNEAL PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2018-06-30 was -$0.15.
- AMNEAL PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2018-03-31 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2019 was -$2.74.
- AMNEAL PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2018 was -$0.16.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$2.74 10-K · filed 2020-03-02 | |||
| 2019-06-30 | -$0.13 10-Q · filed 2019-08-05 | -$0.51 10-Q · filed 2019-08-05 | ||
| 2019-03-31 | -$0.37 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | -$0.16 10-K · filed 2020-03-02 | |||
| 2018-06-30 | -$0.15 10-Q · filed 2019-08-05 | -$0.15 10-Q · filed 2019-08-05 | -$0.45 derived: net income ÷ weighted average shares · filed 2020-03-02 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-15 | $0.00 derived: net income ÷ weighted average shares · filed 2020-03-02 | ||
| 2017-12-31 | $0.00 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |